← Back to guidelines
Psychiatry26 papers

Episode of harmful use of barbiturate

Last edited: 4/10/2026

Overview

Barbiturate use disorder is characterized by a pattern of harmful use of barbiturates. This summary focuses on the management of alcohol withdrawal syndrome (AWS) where phenobarbital, a barbiturate, is considered as a treatment option.

Diagnosis

No diagnostic criteria or grading were provided in the abstracts.

Management

  • Phenobarbital (PB) is being evaluated as an alternative therapy for alcohol withdrawal syndrome (AWS) in the emergency department (ED) 1.
  • Studies are comparing the safety and efficacy of PB to benzodiazepines (BZDs) for AWS treatment 1.
  • Outcomes assessed include intensive care unit (ICU) admission, hospital admission, ED readmission after discharge, and adverse events 1.
  • Special Populations

    No information on special populations was provided in the abstracts.

    Key Recommendations

  • Phenobarbital is considered as an alternative therapy to benzodiazepines for the treatment of alcohol withdrawal syndrome in the emergency department 1. (Evidence: Moderate)
  • When evaluating phenobarbital for alcohol withdrawal, assess outcomes such as ICU admission, hospital admission, ED readmission, and adverse events 1. (Evidence: Moderate)
  • References

    1 Lee CM, Dillon DG, Tahir PM, Murphy CE. Phenobarbital treatment of alcohol withdrawal in the emergency department: A systematic review and meta-analysis. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2024. link

    Original source

    1. [1]
      Phenobarbital treatment of alcohol withdrawal in the emergency department: A systematic review and meta-analysis.Lee CM, Dillon DG, Tahir PM, Murphy CE Academic emergency medicine : official journal of the Society for Academic Emergency Medicine (2024)
    2. [2]
      When is it appropriate to intervene?Steele M, Mass H Nursing BC (1997)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG